Evidence map›Paper›PMID 30693692›Full record

ArticleZhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences2018

[Anti-inflammatory effect of interleukin-35 in mice with colitis and its mechanism].

Zhanjun Lu, Yangyang Hu, Sisi Li, Lijuan Zang, Weiliang Jiang, Jianjiong Wu, Xiening Wu, Yue Zeng, Xingpeng Wang

Open access · greenAbstract read
In one paragraph

Article in Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 78% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Zhanjun LuDepartment of Gastroenterology, Shanghai General Hospital of Nanjing Medical University, Shanghai 200080, China.
Yangyang HuDepartment of Gastroenterology, Shanghai General Hospital, Shanghai 200080, China.
Sisi LiDepartment of Gastroenterology, Shanghai General Hospital, Shanghai 200080, China.
Lijuan ZangPathology Center, Shanghai General Hospital, Shanghai 200080, China.
Weiliang JiangDepartment of Gastroenterology, Shanghai General Hospital, Shanghai 200080, China.
Jianjiong WuDepartment of Gastroenterology, Shanghai General Hospital, Shanghai 200080, China.
Xiening WuDepartment of Gastroenterology, Shanghai General Hospital, Shanghai 200080, China.
Yue ZengDepartment of Gastroenterology, Shanghai General Hospital, Shanghai 200080, China.
Xingpeng WangDepartment of Gastroenterology, Shanghai General Hospital of Nanjing Medical University, Shanghai 200080, China.
SAIC-GM (China) · CNShanghai Medical College of Fudan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate the anti-inflammatory effect and mechanisms of interleukin-35 (IL-35) in inflammatory bowel disease.

methodsBALB/c mice were divided into three groups with 10 mice in each group:control group, model group (oral administration of 4% glucan sodium sulfate for 7 d) and IL-35-treated group (oral administration of 4% glucan sodium sulfate for 7 d, intraperitoneal injection of 2 μg IL-35 at d2-5). Disease activity index (DAI) was scored every day. After 7 d, the mice were sacrificed, and the serum and intestinal tissue samples were collected. The gross morphology of the colon was observed; HE staining was used to observe the pathological changes of colon tissue; flow cytometry was employed to detect the change of macrophage polarization ratio in colon tissue; the mRNA expression levels of cytokines IL-6, TNF-α, IFN-γ, IL-10 and SHIP1 in colon tissue were determined by real-time quantitative RT-PCR; the expression and distribution of SHIP1 in colon tissue was measured by immunohistochemistry; Western blotting was adopted to detect the expression level of SHIP1 protein in colonic intestinal tissues of each group.

resultsThe DAI scores of the mice in the model group were higher than those in the control group, while the DAI scores in the IL-35-treated group were lower than those in the model group (all

conclusionsIL-35 can inhibit the polarization of M1 macrophages and regulate inflammatory cytokines to promote anti-inflammatory effect on mice with colitis.

Indexed as

Anti-Inflammatory AgentsColitisColonDisease Models, AnimalGene Expression RegulationInterleukinsAnimalsCytokinesGlucansInterleukin-6MacrophagesMiceMice, Inbred BALB CPhosphatidylinositol-3,4,5-Trisphosphate 5-PhosphatasesAnti-Inflammatory AgentsCytokinesGlucansglucan sulfateInpp5d protein, mouseinterleukin-35, mouseInterleukin-6InterleukinsPhosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases

Identifiers

PMID30693692
PMCPMC10393646
OpenAlexW3025553548

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.